Abstract
C26H17ClFN3OS, monoclinic, P21/c (no. 14), a = 6.4955(2) Å, b = 14.6143(5) Å, c = 22.6492(8) Å, β = 94.568(1)°, V = 2143.20(12) Å3, Z = 4, Rgt(F) = 0.0461, wRref(F2) = 0.1069, T = 100 K.
Show Summary Details
More options …
More options …
Zeitschrift für Kristallographie - New Crystal Structures
Editor-in-Chief: Huppertz, Hubert
Ed. by Reiß, Guido
6 Issues per year
IMPACT FACTOR 2016: 0.152
Cite Score 2016: 0.15
SCImago Journal Rank (SJR) 2016: 0.123
Source Normalized Impact per Paper (SNIP) 2016: 0.196
Open Access
- Online
- ISSN
- 2197-4578
See all formats and pricing
*Prices in US$ apply to orders placed in the Americas only. Prices in GBP apply to orders placed in Great Britain only. Prices in € represent the retail prices valid in Germany (unless otherwise indicated). Prices are subject to change without notice. Prices do not include postage and handling if applicable. RRP: Recommended Retail Price.
- Most Downloaded Articles
Most Downloaded Articles
- Crystal structure of ethyl 2-(5-methyl-4H-1,2,4-triazol-3-yl)acetate, C7H11N3O2 by Zhu, Guang-Zhou/ Xu, Suo-Ping and Yang, Zhong-Ming
- Crystal structure of lignocaine tetrachlorocobaltate,(C14H22ON2)4(CoCl4)2 by Sridhar, M. A./ Indira, A./ Qayyas, Ν. N. A. and Prasad, J. Shashidhara
- Crystal structure of 4-formylphenyl-diphenylamine, C19H15NO by Li1, Xiaochuan/ LimUI, Woo Taik/ Kimlv, Sung-Hoon and Son, Young-Α
- Crystal structure of mercury(II) trihydrogenhexaoxoiodate(VII), HgH3IO6 by Mormann, Th. J. and Jeitschko, W.
- Crystal structure of 2-(4-(diphenylamino)benzylidene)malononitrile, C22H15N3 by Li, Xiaochuan/ Lim, Woo Taik/ Kim, Sung-Hoon and Son, Young-Α
- Crystal structure of lithium disulfate, Li2[S2O7], Li2O7S2 by Logemann, Christian/ Witt, Julia and Wickleder, Mathias S.
- Crystal structure of l-(benzyloxy)urea, C8H10N2O2 by Mai, Xi/ Xia, Hong-Ying/ Cao, Yu-Sheng/ Lu, Xiao-San and Liao, Yi-Jing
- Crystal structure of barium distannide, BaSn2 by Kim, Sung-Jin and Fässler, Thomas F.
- Crystal structure of potassium trans-diaquabis[oxalato-κ2O,O] chromate(III) urea disolvate, K[Cr(C2O4)2(H2O)2]·2CO(NH2)2, C6H12CrKN4O12 by Bebga, Gouet/ Ndassa, Ibrahim M./ Ndong, Pierre R./ Misse, Patrick R. N. and Fokwa, Boniface P. T.
- Crystal structure of [chlorobis(1,10-phenanthroline)copper(II)] chloride 3,5-dihydroxybenzoic acid solvate monohydrate, [CuCl(C12H8N2)2]Cl · C6H3(OH)2COOH · H2O by He, H.-Y./ Zhou, Y.-L./ Chen, Y.-N. and Zhu, L.-G.
- Refinement of the crystal structure of praseodymium orthoscandate, PrScO3 by Gesing, Thorsten M./ Uecker, Reinhard and Buhl, J.-Christian
- Crystal structure of 1-((2R,3R,4S,5R)-3,4-dihydroxy-5-hydroxymethyltetrahydrofuran- 2-yl)-2-propylsulfanyl-1H-pyrimidin-4-one, C12H18N2O5S by Euler, Harald/ Euler, Harald/ Ali, El-Tayebn and Müller, Christa
- Crystal structure of N-benzy 1-N- 1,3,4-tetramethyl- 2,5-dioxo-4-imidazolidinecarboxamide, C15H19N3O3 by Euler, H./ Kirfel, A./ Meusel, M. and Gütschow, M.
- Crystal structure of 2,4,5-tribromo-1 -methyl- 1H-imidazole, C4H3Br3N2 by Peppel, Tim and Köckerling, Martin
- Crystal structure of dimethyl 5-(acridin-9-yloxy)isophthalate - methanol (1:1), C23H17NO5 · CH3OH by Jimenez, M. Belen/ Gonzalez, Francisca Sanz and Caballero, M. Cruz
- Refinement of the crystal structure of potassium hexaaquairon(II) sulfate, K2[Fe(H2O)6](SO4)2 and potassium hexaaquazinc(II) sulfate, K2[Zn(H2O)6](SO4)2 by Euler, Harald/ Barbier, Bruno/ Meents, Alke and Kirfel, Armin
- Crystal structure of N-[(methylsulfonyl)oxy]-N-((E)-2-(methylsulfonyl) oxy]imino-1,2-diphenylethylidene)amine, C16H16N2O6S2 by Warad, Ismail/ Ghazzali, Mohammed/ Al-Resayes, Saud/ Al-Farhan, Khalid and Al-Othman, Zied
- Crystal structure of diaquabis(1,10-phenanthroline-κ2N,N')sodium chloride, [Na(H2O)2(C12H8N2)2]Cl by Zhang, B.-S.
- Refinement of the crystal structure of tetrasodium tetrasilicide, Na4Si4 by Goebel, Thorsten/ Prots, Yurii and Haarmann, Frank
- Crystal structure of tetraaqua-bis(2-(4-pyridyl)thiazole-4- carboxylate)zinc(II), Zn(H2O)4(C9H5O2N2S)2 by Qin, Jian-Hua/ Song, Ge and Li, Wei
- Frontmatter
- Crystal structure of poly[aqua(μ-2,5-bis(4-pyridyl)-1,3,4-oxadiazole-κ,)(μ-1,3-phenylenediacetato-κ,′:′′)cobalt(II)], CHCoNO
- Crystal structure of 2-amino-7,7-dimethyl-5-oxo-4-(3-phenoxy-phenyl)-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile
- Crystal structure of (E)-4,4′-(diazene-1,2-diyl)bis(1-nitro-1H-1,2,4-triazol-5(4H)-one)—acetonitrile (1:1), CHNO
- Crystal structure of potassium ()-5-oxo-4-((5-oxo-1-1,2,4-triazol-4(5)-yl)diazenyl)-4,5-dihydro-1,2,4-triazol-1-ide – ()-4,4-diazene-1,2-diylbis(2,4-dihydro-3-1,2,4-triazol-3-one) – methanol (1/1/1), CHNKO
- Crystal structure of (,′-bis(2-(((2,6-diisopropylphenyl)imino)methyl)phenyl)benzene-1,2-diamido-κ,′,′′,′′′)oxidovanadium(IV), CHNOV
- Crystal structure of 5,5-bis(4-iodophenyl)-5-cyclopenta[2,1-:3,4-′]dipyridine, CHIN
- Crystal structure of aquadichloridobis(1-((2-methyl-1-imidazol-1-yl)methyl)-1-benotriazole-κN)mercury(II), CHClHgNO
- Crystal structure of 2-[4-(1-imidazol-1-yl)phenyl]-1-benzimidazol-3-ium [2-(carboxymethyl)phenyl]acetate monohydrate, CHNO
- Crystal structure of 4,4′-bipiperidinium dichloride 0.12 hydrate, CHNCl · 0.12 HO
- Crystal structure of catena-poly[tetraaqua(μ-4,4′()-ethene-1,2-diyldipyridine-κ:′)nickel(II)] bis(6-methyl-2-oxo-1,2-dihydro-pyridine-4-carboxylate) pentahydrate, CHNONi
- Crystal structure of ethyl-5-amino-1-(2,4-dinitrophenyl)-1-pyrazole-4-carboxylate, CHNO
- Crystal structure of dicarbonyl(pyridin-2-olate-1-oxido-κ,′)rhodium(I), CHNORh
- Crystal structure of 1-(adamantan-1-yl)-3-(4-chlorophenyl)thiourea, CHClNS
- Crystal structure of 2-((2-chloropyridin-3-ylamino)methylene)malononitrile, CHClN
- Crystal structure of tetraaquabis(μ-4-chlorobenzoato-κ:,′)bis(4-chlorobenzoato-κ)bis(1,10-phenanthroline-κ,′)distrontium(II), CHClNOSr
- Crystal structure of 3-hydroxy-3-phenyl-1,3-dihydro-2-indol-2-one, CHNO
- Crystal structures of bis(1,10-phenanthrolin-1-ium) aquapentakis(nitrato-κ,′)neodym(III) monohydrate, CHNNdO
- Crystal structure of 2-ethyl-1--butyl 3-oxo-2-[phenyl(-butoxycarbonylamino)methyl]-1,2-pyrrolidinedicarboxylate, CHNO
- Crystal structure of poly[diaquabis(μ-benzene-1,3,5-tricarboxylato-κ,κ:κ,κ:κ:κ)-bis(μ-4,4′-benzene-1,3-diylbis(4-1,2,4-triazole-κ:′)tricadmium(II)] tetrahydrate, CHCdNO
- Crystal structure of -dichlorido[1,3-bis(9-methyl-9H-fluoren-9-yl) benzimidazol-2-ylidene](pyridine)palladium(II) – a compound with anagostic CH–Pd interactions, CHClNPd
- Crystal structure of catena-poly[(μ-5-(4-(tetrazol-1-id-5-yl)phenoxy)benzene-1,3-dicarboxyato-κ:′:)(4-(3-(pyridin-4-yl)propyl)pyridinium-κ)zinc(II)], CHZnNO
- Crystal structure of 3,6-di-2-pyridinyl-4-pyridazine carbonitrile, CHN
- Crystal structure of 5,5,9,13-tetramethyltetracyclo[10·2·1·0·0]pentadecane-3,7,14-triol, CHO
- Crystal structure of 2-amino-7-methyl-5-oxo-4-phenyl-4,5-pyrano[4,3-]pyran-3-carbonitrile, CHNO
- Crystal structure of the poly[(1,10-phenanthroline-κ,′)(μ-carboxylatophenoxyacetato-κ′:′′;′′′)lead(II)] monohydrate, CHNOPb
- Crystal structure of the poly[(μ-biphenyl-4,4′-dicarboxylato-κ:′:′′:′′′) bis(μ-8-(11-(oxysulfonyl)-4-silbenyl)-2-(oxysulfonyl)stilbene-κ:′:′′,′′′) bis(1,10-phenanthroline-k,′) dipraseodymium(III)], CHNOPrS
- Crystal structure of 3-iodo-5-methoxy-7-(methoxymethoxy)-4-(3-methoxyphenoxy)-2-chromen-2-one, CHIO
- Crystal structure of poly[(5-carboxy-2,6-dimethylpyridinium-3-carboxylato-κ)tris(μ-2,6-dimethylpyridinium-3,5-dicarboxylato-κ,′:′′)erbium(III)], CHErNO
- This molecule targets at type 2 diabetes - a single crystal study on (2,3,5)-2-(2,5-difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-]pyrazol-5(4)-yl] tetrahydro-2-pyran-3-amine (Omarigliptin), CHFNOS
- Crystal structure of poly[(μ-2,2′-benzene-1,2-diyldiacetato-κ:′), (μ-1-(4-(1-imidazol-1-yl)benzyl)-1-1,2,4-triazole-κ:′)zinc(II)], CHNOZn
- Crystal structure of tetraaqua(μ-3-(3,5-dicarboxyphenoxy)benzene-1,2-dicarboxylato-κ:′)manganese(II) dihydrate, CHOMn
- Crystal structure of 4,4′-sulfonyldipyridine, CHNOS
- Crystal structure of 4-[()-(2-chloro-6-fluorobenzylidene)amino]-1,2-dihydro-2,3-dimethyl-1-phenylpyrazol-5-one, CHClFNO
- Crystal structure of carbonyl(2-oxopyridin-1(2)-olato-κ, ′)(triphenylphosphine-κ)rhodium(I), CHNOPRh
- Crystal structure of diaquabis(2-(3-bromophenyl)-5-carboxy-1-imidazol-4-carboxylato-κ,) cobalt(II) trihydrate, CHBrCoNO
- Crystal structure of 4-(pyridin-4-ylmethylsulfonyl)pyridine, CHNOS
- Crystal structure of poly[(μ-1-methyl-1-tetrazole-5-thiolato-κ:::′)copper(I)], CHCuNS
- Crystal structure of poly[diaquabis(μ-4,4′-sulfinyldipyridine-κ,′)zinc(II)] diperchlorate dihydrate, CHNOSClZn
- Crystal structure of (1-((1-benzylpyrrolidin-2-yl-κ)methyl)-3-isopropyl-1-imidazol-2(3)-ylidene–κ)dibromidopalladium(II), CHBrNPd
- Crystal structure of pentacalcium tetranitridovanadate(V) mononitride based on a powder diffraction study, Ca[VN]N
- Crystal structure of ((1-((1-benzylpyrrolidin-2-yl)methyl)-3-ethyl-1-imidazol-2(3)-ylidene)-κ,)dichloridopalladium(II), CHClNPd
- Crystal structure of 9-allyl-4,5-dichloro-12-cyano-9,10-dihydro-9,10-ethanoanthracen-12-yl acetate, CHClNO
- Crystal structure of 4-bromo-2-(8-(3-ethoxy-2-hydroxyphenyl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl)phenol, CHBrNO
- Crystal structure of 3--butyl-3-hydroxy-1,3-dihydro-2-pyrrolo[3,2-]pyridin-2-one, CHNO
- Crystal structure of diaquabis(3-(3,5-dibromophenyl)-5-(pyridin-2-yl)-1,2,4-triazol-4-ido-κ,′)nickel(II) mono hydrate, CHBrNNiO
- Crystal structure of 5-(adamantan-1-yl)-3-[(2-trifluoromethylanilino)methyl]-2,3-dihydro-1,3,4-oxadiazole-2-thione, CHFNOS
- Crystal structure of 2-ethyl-1--butyl-2-((4-fluorophenyl)(-butoxycarbonylamino)methyl)-3-oxo-pyrrolidine-1,2-dicarboxylate, CHFNO
- Crystal structure of bis(μ-2-fluorobenzoato-κ::′) bis(μ-2-fluorobenzoato-κ:′)dinitrato-κ,′ bis(1,10-phenathroline-κ,′)diterbium(III), CHFNOTb
- Crystal structure of tetrabutylammonium 4-aminobenzenesulfonate 2/3 hydrate, CHNOS · 2/3 HO
- Crystal structure of tetraethylammonium 4-aminobenzenesulfonate, CHNOS
- Crystal structure of bis(guanidinium) 3,3′-oxybis(6-carboxybenzoate), CHNO
- Crystal structure of ′-(4-methoxybenzylidene)-5-phenyl-1-pyrazole-3-carbohydrazide, CHNO
- Crystal structure of ′-(4-nitrobenzylidene)-5-phenyl-1-pyrazole-3-carbohydrazide, CHNO
- Crystal structure of 5-((4-bromophenyl)(2-hydroxy-6-oxocyclohex-1-en-1-yl)methyl)-6-hydroxy-1,3-dimethylpyrimidine-2,4(1,3)-dione, CHBrNO
- Crystal structure of 3-(((cyclohexyl(phenyl)methylidene)amino)oxy)-2-hydroxy--(propan-2-yl)propan-1-aminium chloride, CHClNO
- Crystal structure of 6-hydroxy-5-((2-hydroxy-6-oxocyclohex-1-en-1-yl)(phenyl)methyl)-1,3-dimethylpyrimidine-2,4(1,3)-dione, CHNO
- Crystal structure of 2-(4-(4-bromophenyl)thiazol-2-yl)isoindoline-1,3-dione, CHBrNOS
- Crystal structure of 2-(4-methylbenzoyl)pyrene, CHO
- Crystal structure of -(5-bromo-4-(-tolyl)thiazol-2-yl)-4-chlorobutanamide, CHBrClNOS
- Crystal structure of 4,5-diphenylthiazol-2-amine, CHNS
- Crystal structure of poly[bis(μ-4-(3-(pyridin-3-yl)-1-1,2,4-triazol-5-yl)benzoato-κ:,′)-lead(II)], CHONPb
- Crystal structure of ()-4-(4-oxopent-2-en-2-ylamino)benzenesulfonamide, CHNOS
- Crystal structure of poly[(μ-2-methyl-1-(4-(2-methyl-2-benzo[] imidazol-1(7a)-yl)butyl)-1-benzo[]imidazole-κ:′)bis(μ-5--butylbenzene-1,3-dicarboxylato-κ:,′:′′,′′′)dicadmium(II)] tetrahydrate, CHCdNO
- Crystal structure of catena-poly-[aqua(μ-4,4′-bipyridine-κ:′)bis(3′,5,5′-tricarboxybiphenyl-2-carboxylato-κ,′)cadmium(II)], CHNOCd
- Crystal structure of (2,3)-1-(4-chlorophenyl)-4,4-dimethyl-2-(1-1,2,4-triazol-1-yl)pentan-3-ol, CHClNO
- Crystal structure of ′-(4-(dimethylamino)benzylidene)-5-phenyl-1-pyrazole-3-carbohydrazide, CHNO
- Crystal structure of 3-(benzofuran-2-yl)-5-(4-fluorophenyl)-4,5-dihydro-1pyrazole-1-carbothioamide, CHFNOS
- Crystal structure of -1-acetoxy-7,14-di-hydroxy-7,20-epoxykaur-16-en-15-one, CHO
- Crystal structure of 1,7-dihydroxy-11-acetoxy--7,20-epoxykaur-16-en-15-one, CHO
- Crystal structure of 7β,14β,15β-trihydroxy-1α-acetoxy-7α,20-epoxy--kaurane, CHO
- Crystal structure of -1β,7α,11α-trihydroxy-7β,20-epoxykaur-16-en-15-one, CHO
- Crystal structure of poly-[tetraaquabis(μ-benzene-1,2,4,5-tetracarboxylato-1κ:::2κ::::3κ:::)(di-μ-hydroxido)-pentazinc(II)] decahydrate, CHOZn
- Crystal structure of 1-(4-methylthiazol-2-yl)-3-propylthiourea, CHNS
- Crystal structure of 2-((dimethylamino)methylene)-5,5-Dimethylcyclohexane-1,3-dione, CHNO
- Crystal structure of poly[1,4-bis(2-methylbenzimidazol)butane-κ:′)bis(4,4′-oxybis(benzoato-κ,′:′′,′′′)dicadmium] monohydrate, CHCdNO
- Crystal structure of 2-(3-(benzofuran-2-yl)-5-(4-fluorophenyl)-4,5-dihydro-1-pyrazol-1-yl)-4-(4-chlorophenyl)thiazole, CHClFNOS
- Crystal structure of bis(μ-isophthalato-:′:′′)(μ-1,4-\ bis((2-propyl-1-benzo[]imidazol-1-yl)methyl)benzene-κ:′)dizinc(II), CHNOZn
- Crystal structure of poly[bis(adipate-κ,′:′′, ′′′)(1,4-bis(2-methyl-1-benzo[]imidazol-1-yl)benzene-κ:′)dizinc(II), CHNOZn
- Crystal structure of -(2-(2-oxoindolin-4-yl)ethyl)--propylpropan-1-aminium tetraphenylborate, CHBNO
- Crystal structure of 1-(2,3-dihydro-4-methyl-3-phenyl-2-thioxothiazol-5-yl)-1-ethanone, CHNOS
- Crystal structure of 3-(adamantan-1-yl)-1-[(4-benzylpiperazin-1-yl)methyl]-4-[()-(2,6-difluorobenzylidene)amino]-1-1,2,4-triazole-5(4)-thione, CHFNS
- Crystal structure of 6-(4-chlorophenyl)-3-(thiophen-2-yl)-[1,2,4]triazolo[3,4-][1,3,4]-thiadiazole, CHClNS
- Crystal structure of bis(ethanaminium) poly[bis(hexaselenido-,)palladate(II)], CHNPdSe
- Crystal structure of 2-(3-(benzofuran-2-yl)-5-phenyl-4,5-dihydro-1-pyrazol-1-yl)-4-phenylthiazole, CHNOS
- Crystal structure of -[bis(-5-hydroxyisophtalato-κ:′:′′)(-1,4-bis(2-ethylbenzimidazol-1-ylmethyl)benzene-κ:′)dizinc(II)], CHNOZn
- Crystal structure of -[(μ-1,4-bis(2-ethylbenzimidazol-1-ylmethyl)benzene-κ:′)-bis(μ-2,2′-(1,3-phenylene)diacetate-κ:′:′′:′′′)dizinc(II)], CHNOZn
- Crystal structure of 5,17-bis-cyano-25,26,27,28-tetrapropyloxy-calix[4]arene, CHNO
- Crystal structure of -[μ-1,4-bis(2-ethylbenzimidazol-1-ylmethyl)benzene-κ:′)-bis(μ-5-hydroxyisophthalate(2–)-κ,′:′′)dicadmium(II)] monohydrate, CHNOCd
- Crystal structure of -[μ-1,4-bis(2-ethylbenzimidazol-1-ylmethyl)benzene-κ:′)-bis(μ-4,4′-sulfonyldibenzoato-κ:′:′′:′′′)dicadmium(II)] monohydrate, CHNOCd
- Crystal structure of -[bis(μ-adipato-κ:′:′′:′′′)(μ-1,4-bis((2-ethyl-1-benzo[]imidazol-1-yl)methyl)benzene-κ:′)dizinc(II)], CHNOZn
- Crystal structure of (2-(2-chlorophenyl)-5-methyl-1,3-dioxan-5-yl)methanol, CHClO
- Crystal structure of 2-(4-Bromophenyl)-5-ethyl-1,3-dioxane-5-carboxylic acid, CHBrO
- Crystal structure of (2-(4-bromophenyl)-5-ethyl-1,3-dioxan-5-yl)methanol, CHBrO
- Crystal structure of 3-((1,3,5,7-tetraoxo-6-(pyridin-3-ylmethyl)-3,3a,4,4a,5,6,7,7a,8,8a-decahydro-4,8-ethenopyrrolo[3,4-]isoindol-2(1)-yl)methyl)pyridin-1-ium-κ-trichloridocobalt(II) hemihydrate, CHClCoNO
- Crystal structure of 4-chloro-4′,6′-dichloro-2,2′-[propane-1,3-diyldioxybis(nitrilomethylidyne)]-diphenol, CHClNO
- Crystal structure of 2-amino-4-(3-trifluoromethylphenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile, CHFNO
- Crystal structure of bis(benzoato-κ)bis(4,4′-((1-1,2,4-triazol-1-yl)methylene)dibenzonitrile-κ)zinc(II), CHNOZn
- Crystal structure of 3-methyl-2-chromen-2-one, CHO
- Crystal structure of -[aqua-(2-carboxy-5-(3-carboxy-5-carboxylatophenoxy)benzoato-κ)(μ-4,4′-di(1-imidazol-1-yl)-1,1′-biphenyl-κ:′)cobalt(II)], CHNOCo
- Crystal structure of 4,4′-di(1-imidazol-1-yl)-1,1′-biphenyl, CHN
- Crystal structure of 1-(3-chloropropyl)piperidin-1-ium tetraphenylborate, CHBClN
- Crystal structure of dimethyl 5-(benzylamino)isophthalate, CHNO
- Crystal structure of dimethyl 5-(dibenzylamino)isophthalate, CHNO
- Crystal structure of -(adamantan-1-yl)-4-phenylpiperazine-1-carbothioamide, CHNS
- Crystal structure of (2,2′(cyclohexane-1,2-diylbis(nitrilo()methylylidene))diphenolato-κ,′,,′)dimethanolmanganese(III) bromide, CHBrMnNO
- Crystal structure of 3,5,7-tris(morpholinomethyl)tropolone·0.67 hydrate, CHNO·0.67HO
- Crystal structure of biphenyl-2,3′,5,5′-tetracarboxylic acid – 4,4′-biphenyl-4,4′-diyldipyridine (3/2), CHNO
Crystal structure of 2-(3-(benzofuran-2-yl)-5-(4-fluorophenyl)-4,5-dihydro-1H-pyrazol-1-yl)-4-(4-chlorophenyl)thiazole, C26H17ClFN3OS
Gamal A. El-Hiti
- Corresponding author
- Cornea Research Chair, Department of Optometry, College of Applied Medical Sciences, King Saud University, P. O. Box 10219, Riyadh 11433, Saudi Arabia
- Other articles by this author:
- De Gruyter OnlineGoogle Scholar
- Department of Chemistry, College of Science and Humanities, Shaqra University, Duwadimi, Saudi Arabia
- Applied Organic Chemistry Department, National Research Centre, Dokki, Giza, Egypt
- Other articles by this author:
- De Gruyter OnlineGoogle Scholar
- Department of Chemistry, College of Science and Humanities, Shaqra University, Duwadimi, Saudi Arabia
- Other articles by this author:
- De Gruyter OnlineGoogle Scholar
- Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P. O. Box 2457, Riaydh 11451, Saudi Arabia
- Department of Medicinal Chemistry, Faculty of Pharmacy, University of Mansoura, Mansoura 35516, Egypt
- Other articles by this author:
- De Gruyter OnlineGoogle Scholar
Published Online: 2016-04-07 | DOI: https://doi.org/10.1515/ncrs-2016-0004
Open Access
This article offers supplementary material which is provided at the end of the article.
CCDC no.:: 1443916
The crystal structure is shown in the figure. Tables 1 and 2 contain details of the measurement method and a list of the atoms including atomic coordinates and displacement parameters.
Table 1:
Data collection and handling.
Table 2:
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).
Source of material
Reaction of 3-(benzofuran-2-yl)-5-(4-fluorophenyl)-4,5-dihydro-1H-pyrazole-1-carbothioamide and 2-bromo-1-(4-chlorophenyl)ethanone in ethanol under reflux for 3 h provided the crude product. Crystallization from dimethylformamide gave colorless crystals of the title compound (Mp 176–178 °C) [1].
Experimental details
Cell refinement and data reduction were carried out by Bruker SAINT [6].
Discussion
Pyrazolylthiazole derivatives exhibit anti-inflammatory [2], antimicrobial activities [2] and cause antinociception in mice [3]. Also, some derivatives are useful as DF508-cystic fibrosis transmembrane conductance regulators that have improved hydrophilicity compared to bithiazoles [4].
The asymmetric unit of the title structure contains only one independent molecule with a central pyrazol ring (N1/N2/C9—C11) which makes dihedral angles of 1.05 (2)°, 2.85 (2)° and 77.25 (3)° with benzofuran ring (O1/C1—C8), thiazol ring (S1/C18/N3/C19/C20) and fluorophenyl ring (C12—C17), respectively. There is one hydrogen bond: C23—H23A⋯F1i with symmetry code: i = −x+1, y+1/2, −z+1/2.
Acknowledgements:
The authors extend their appreciation to the College of Applied Medical Sciences Research Centre and the Deanship of Scientific Research at King Saud University for their funding of this research.
References
- 1.
Mohamed, H. A.; Abdel-Latif, E.; Abdel-Wahab, B. F.; Awad, G. E. A.: Novel antimicrobial agents: fluorinated 2-(3-(benzofuran-2-yl) pyrazol-1-yl)thiazoles. Inter. J. Med. Chem. 2013 (2013) Article ID 986536, 6 pages. http://dx.doi.org/10.1155/2013/986536. Google Scholar
- 2.
Hu, W.-X.; Rao, G. W.; Sun, Y. Q.: Synthesis and antitumor activity of s-tetrazine derivatives. Bioorg. Med. Chem. Lett. 14 (2004) 1177–1181. Google Scholar
- 3.
Prokopp, C. R.; Rubin, M. A.; Sauzem, P. D.; de Souza, A. H.; Berlese, D. B.; Lourega, R. V.; Muniz, M. N.; Bonacorso, H. G.; Zanatta, N.; Martins, M. A.; Mello, C. F.: A pyrazolyl-thiazole derivative causes antinociception in mice. Braz. J. Med. Biol. Res. 39 (2006) 795–799. Google Scholar
- 4.
Ye, L.; Knapp, J. M.; Sangwung, P.; Fettinger, J. C.; Verkman, A. S.; Kurth, M. J.: Pyrazolylthiazole as ΔF508-cystic fibrosis transmembrane conductance regulator correctors with improved hydrophilicity compared to bithiazoles. J. Med. Chem. 53 (2010) 3772–3781. Web of ScienceGoogle Scholar
- 5.
Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122. Google Scholar
- 6.
Bruker: SAINT-Plus, SHELXTL and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA, 2004. Google Scholar
About the article
Received: 2016-01-03
Accepted: 2016-03-07
Published Online: 2016-04-07
Published in Print: 2016-09-01
Citation Information: Zeitschrift für Kristallographie - New Crystal Structures, Volume 231, Issue 3, Pages 911–912, ISSN (Online) 2197-4578, ISSN (Print) 1433-7266, DOI: https://doi.org/10.1515/ncrs-2016-0004.
©2016 Gamal A. El-Hiti et al., published by De Gruyter.. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. BY-NC-ND 3.0
Supplementary Article Materials
Related Content
Loading ...
- Frontmatter
- Crystal structure of poly[aqua(μ2-2,5-bis(4-pyridyl)-1,3,4-oxadiazole-κ2N,N)(μ2-1,3-phenylenediacetato-κ3O,O′:O′′)cobalt(II)], C22H18CoN4O6
- Crystal structure of 2-amino-7,7-dimethyl-5-oxo-4-(3-phenoxy-phenyl)-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile
- Crystal structure of (E)-4,4′-(diazene-1,2-diyl)bis(1-nitro-1H-1,2,4-triazol-5(4H)-one)—acetonitrile (1:1), C6H5N11O6
- Crystal structure of potassium (E)-5-oxo-4-((5-oxo-1H-1,2,4-triazol-4(5H)-yl)diazenyl)-4,5-dihydro-1,2,4-triazol-1-ide – (E)-4,4-diazene-1,2-diylbis(2,4-dihydro-3H-1,2,4-triazol-3-one) – methanol (1/1/1), C9H11N16KO5
- Crystal structure of (N,N′-bis(2-(((2,6-diisopropylphenyl)imino)methyl)phenyl)benzene-1,2-diamido-κ4O,O′,O′′,O′′′)oxidovanadium(IV), C44H48N4OV
- Crystal structure of 5,5-bis(4-iodophenyl)-5H-cyclopenta[2,1-b:3,4-b′]dipyridine, C23H14I2N2
- Crystal structure of aquadichloridobis(1-((2-methyl-1H-imidazol-1-yl)methyl)-1H-benotriazole-κN)mercury(II), C22H24Cl2HgN10O
- Crystal structure of 2-[4-(1H-imidazol-1-yl)phenyl]-1H-benzimidazol-3-ium [2-(carboxymethyl)phenyl]acetate monohydrate, C26H24N4O5
- Crystal structure of 4,4′-bipiperidinium dichloride 0.12 hydrate, C10H22N2Cl2 · 0.12 H2O
- Crystal structure of catena-poly[tetraaqua(μ2-4,4′(E)-ethene-1,2-diyldipyridine-κ2N:N′)nickel(II)] bis(6-methyl-2-oxo-1,2-dihydro-pyridine-4-carboxylate) pentahydrate, C26H42N4O15Ni
- Crystal structure of ethyl-5-amino-1-(2,4-dinitrophenyl)-1H-pyrazole-4-carboxylate, C12H11N5O6
- Crystal structure of dicarbonyl(pyridin-2-olate-1-oxido-κ2O,O′)rhodium(I), C7H4NO4Rh
- Crystal structure of 1-(adamantan-1-yl)-3-(4-chlorophenyl)thiourea, C17H21ClN2S
- Crystal structure of 2-((2-chloropyridin-3-ylamino)methylene)malononitrile, C9H5ClN4
- Crystal structure of tetraaquabis(μ2-4-chlorobenzoato-κ2O:O,O′)bis(4-chlorobenzoato-κO)bis(1,10-phenanthroline-κ2N,N′)distrontium(II), C52H40Cl4N4O12Sr2
- Crystal structure of 3-hydroxy-3-phenyl-1,3-dihydro-2H-indol-2-one, C14H11NO2
- Crystal structures of bis(1,10-phenanthrolin-1-ium) aquapentakis(nitrato-κ2O,O′)neodym(III) monohydrate, C24H22N9NdO17
- Crystal structure of 2-ethyl-1-tert-butyl 3-oxo-2-[phenyl(tert-butoxycarbonylamino)methyl]-1,2-pyrrolidinedicarboxylate, C24H34N2O7
- Crystal structure of poly[diaquabis(μ4-benzene-1,3,5-tricarboxylato-κO1,κO2:κO3,κO4:κO5:κO6)-bis(μ2-4,4′-benzene-1,3-diylbis(4H-1,2,4-triazole-κ2N:N′)tricadmium(II)] tetrahydrate, C38H34Cd3N12O18
- Crystal structure of trans-dichlorido[1,3-bis(9-methyl-9H-fluoren-9-yl) benzimidazol-2-ylidene](pyridine)palladium(II) – a compound with anagostic CH–Pd interactions, C40H31Cl2N3Pd
- Crystal structure of catena-poly[(μ3-5-(4-(tetrazol-1-id-5-yl)phenoxy)benzene-1,3-dicarboxyato-κ3O:O′:N)(4-(3-(pyridin-4-yl)propyl)pyridinium-κN)zinc(II)], C28H22ZnN6O5
- Crystal structure of 3,6-di-2-pyridinyl-4-pyridazine carbonitrile, C15H9N5
- Crystal structure of 5,5,9,13-tetramethyltetracyclo[10·2·1·01,10·04,9]pentadecane-3,7,14-triol, C20H34O4
- Crystal structure of 2-amino-7-methyl-5-oxo-4-phenyl-4H,5H-pyrano[4,3-b]pyran-3-carbonitrile, C16H12N2O3
- Crystal structure of the poly[(1,10-phenanthroline-κ2N,N′)(μ3-carboxylatophenoxyacetato-κ4O,O′:O′′;O′′′)lead(II)] monohydrate, C21H16N2O6Pb
- Crystal structure of the poly[(μ4-biphenyl-4,4′-dicarboxylato-κ4O:O′:O′′:O′′′) bis(μ3-8-(11-(oxysulfonyl)-4-silbenyl)-2-(oxysulfonyl)stilbene-κ4O:O′:O′′,O′′′) bis(1,10-phenanthroline-k2N,N′) dipraseodymium(III)], C94H64N4O16Pr2S4
- Crystal structure of 3-iodo-5-methoxy-7-(methoxymethoxy)-4-(3-methoxyphenoxy)-2H-chromen-2-one, C19H17IO7
- Crystal structure of poly[(5-carboxy-2,6-dimethylpyridinium-3-carboxylato-κO)tris(μ2-2,6-dimethylpyridinium-3,5-dicarboxylato-κ3O,O′:O′′)erbium(III)], C36H33ErN4O16
- This molecule targets at type 2 diabetes - a single crystal study on (2R,3S,5R)-2-(2,5-difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl] tetrahydro-2H-pyran-3-amine (Omarigliptin), C17H20F2N4O3S
- Crystal structure of poly[(μ2-2,2′-benzene-1,2-diyldiacetato-κ2O:O′), (μ2-1-(4-(1H-imidazol-1-yl)benzyl)-1H-1,2,4-triazole-κ2N:N′)zinc(II)], C22H19N5O4Zn
- Crystal structure of tetraaqua(μ2-3-(3,5-dicarboxyphenoxy)benzene-1,2-dicarboxylato-κ2O:O′)manganese(II) dihydrate, C16H20O15Mn
- Crystal structure of 4,4′-sulfonyldipyridine, C10H8N2O2S
- Crystal structure of 4-[(E)-(2-chloro-6-fluorobenzylidene)amino]-1,2-dihydro-2,3-dimethyl-1-phenylpyrazol-5-one, C18H15ClFN3O
- Crystal structure of carbonyl(2-oxopyridin-1(2H)-olato-κ2O, O′)(triphenylphosphine-κP)rhodium(I), C24H19NO3PRh
- Crystal structure of diaquabis(2-(3-bromophenyl)-5-carboxy-1H-imidazol-4-carboxylato-κ2O,N) cobalt(II) trihydrate, C22H22Br2CoN4O13
- Crystal structure of 4-(pyridin-4-ylmethylsulfonyl)pyridine, C11H10N2O2S
- Crystal structure of poly[(μ4-1-methyl-1H-tetrazole-5-thiolato-κ3S:S:N:N′)copper(I)], C2H3CuN4S
- Crystal structure of poly[diaquabis(μ2-4,4′-sulfinyldipyridine-κ2N,N′)zinc(II)] diperchlorate dihydrate, C20H24N4O14S2Cl2Zn
- Crystal structure of (1-((1-benzylpyrrolidin-2-yl-κN)methyl)-3-isopropyl-1H-imidazol-2(3H)-ylidene–κC)dibromidopalladium(II), C18H25Br2N3Pd
- Crystal structure of pentacalcium tetranitridovanadate(V) mononitride based on a powder diffraction study, Ca5[VN4]N
- Crystal structure of ((1-((1-benzylpyrrolidin-2-yl)methyl)-3-ethyl-1H-imidazol-2(3H)-ylidene)-κ2C,N)dichloridopalladium(II), C17H23Cl2N3Pd
- Crystal structure of 9-allyl-4,5-dichloro-12-cyano-9,10-dihydro-9,10-ethanoanthracen-12-yl acetate, C22H17Cl2NO2
- Crystal structure of 4-bromo-2-(8-(3-ethoxy-2-hydroxyphenyl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl)phenol, C18H19BrN2O5
- Crystal structure of 3-tert-butyl-3-hydroxy-1,3-dihydro-2H-pyrrolo[3,2-c]pyridin-2-one, C11H14N2O2
- Crystal structure of diaquabis(3-(3,5-dibromophenyl)-5-(pyridin-2-yl)-1,2,4-triazol-4-ido-κ2N,N′)nickel(II) mono hydrate, C26H20Br4N8NiO3
- Crystal structure of 5-(adamantan-1-yl)-3-[(2-trifluoromethylanilino)methyl]-2,3-dihydro-1,3,4-oxadiazole-2-thione, C20H22F3N3OS
- Crystal structure of 2-ethyl-1-tert-butyl-2-((4-fluorophenyl)(tert-butoxycarbonylamino)methyl)-3-oxo-pyrrolidine-1,2-dicarboxylate, C24H33FN2O7
- Crystal structure of bis(μ2-2-fluorobenzoato-κ2O:O:O′) bis(μ2-2-fluorobenzoato-κ2O:O′)dinitrato-κ2O,O′ bis(1,10-phenathroline-κ2N,N′)diterbium(III), C52H32F4N6O14Tb2
- Crystal structure of tetrabutylammonium 4-aminobenzenesulfonate 2/3 hydrate, C22H42N2O3S · 2/3 H2O
- Crystal structure of tetraethylammonium 4-aminobenzenesulfonate, C14H26N2O3S
- Crystal structure of bis(guanidinium) 3,3′-oxybis(6-carboxybenzoate), C18H20N6O9
- Crystal structure of N′-(4-methoxybenzylidene)-5-phenyl-1H-pyrazole-3-carbohydrazide, C18H16N4O2
- Crystal structure of N′-(4-nitrobenzylidene)-5-phenyl-1H-pyrazole-3-carbohydrazide, C17H13N5O3
- Crystal structure of 5-((4-bromophenyl)(2-hydroxy-6-oxocyclohex-1-en-1-yl)methyl)-6-hydroxy-1,3-dimethylpyrimidine-2,4(1H,3H)-dione, C19H19BrN2O5
- Crystal structure of 3-(((cyclohexyl(phenyl)methylidene)amino)oxy)-2-hydroxy-N-(propan-2-yl)propan-1-aminium chloride, C19H31ClN2O2
- Crystal structure of 6-hydroxy-5-((2-hydroxy-6-oxocyclohex-1-en-1-yl)(phenyl)methyl)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione, C19H20N2O5
- Crystal structure of 2-(4-(4-bromophenyl)thiazol-2-yl)isoindoline-1,3-dione, C17H9BrN2O2S
- Crystal structure of 2-(4-methylbenzoyl)pyrene, C24H16O
- Crystal structure of N-(5-bromo-4-(p-tolyl)thiazol-2-yl)-4-chlorobutanamide, C14H14BrClN2OS
- Crystal structure of 4,5-diphenylthiazol-2-amine, C15H12N2S
- Crystal structure of poly[bis(μ2-4-(3-(pyridin-3-yl)-1H-1,2,4-triazol-5-yl)benzoato-κ3N:O,O′)-lead(II)], C28H18O4N8Pb
- Crystal structure of (Z)-4-(4-oxopent-2-en-2-ylamino)benzenesulfonamide, C11H14N2O3S
- Crystal structure of poly[(μ2-2-methyl-1-(4-(2-methyl-2H-benzo[d] imidazol-1(7aH)-yl)butyl)-1H-benzo[d]imidazole-κ2N:N′)bis(μ3-5-tert-butylbenzene-1,3-dicarboxylato-κ4O:O,O′:O′′,O′′′)dicadmium(II)] tetrahydrate, C44H54Cd2N4O12
- Crystal structure of catena-poly-[aqua(μ2-4,4′-bipyridine-κ2N:N′)bis(3′,5,5′-tricarboxybiphenyl-2-carboxylato-κ2O,O′)cadmium(II)], C42H28N2O17Cd
- Crystal structure of (2RS,3RS)-1-(4-chlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pentan-3-ol, C15H20ClN3O
- Crystal structure of N′-(4-(dimethylamino)benzylidene)-5-phenyl-1H-pyrazole-3-carbohydrazide, C19H19N5O
- Crystal structure of 3-(benzofuran-2-yl)-5-(4-fluorophenyl)-4,5-dihydro-1Hpyrazole-1-carbothioamide, C18H14FN3OS
- Crystal structure of ent-1β-acetoxy-7α,14α-di-hydroxy-7β,20-epoxykaur-16-en-15-one, C22H30O6
- Crystal structure of 1α,7β-dihydroxy-11β-acetoxy-ent-7β,20-epoxykaur-16-en-15-one, C22H30O6
- Crystal structure of 7β,14β,15β-trihydroxy-1α-acetoxy-7α,20-epoxy-ent-kaurane, C22H32O6
- Crystal structure of ent-1β,7α,11α-trihydroxy-7β,20-epoxykaur-16-en-15-one, C20H28O5
- Crystal structure of poly-[tetraaquabis(μ8-benzene-1,2,4,5-tetracarboxylato-1κ3O4:O6:O8:2κ4O2:O2:O5:O5:3κ4O1:O3:O5:O7)(di-μ3-hydroxido)-pentazinc(II)] decahydrate, C20H34O32Zn5
- Crystal structure of 1-(4-methylthiazol-2-yl)-3-propylthiourea, C8H13N3S2
- Crystal structure of 2-((dimethylamino)methylene)-5,5-Dimethylcyclohexane-1,3-dione, C11H17NO2
- Crystal structure of poly[1,4-bis(2-methylbenzimidazol)butane-κ2N:N′)bis(4,4′-oxybis(benzoato-κ4O,O′:O′′,O′′′)dicadmium] monohydrate, C48H38Cd2N4O10
- Crystal structure of 2-(3-(benzofuran-2-yl)-5-(4-fluorophenyl)-4,5-dihydro-1H-pyrazol-1-yl)-4-(4-chlorophenyl)thiazole, C26H17ClFN3OS
- Crystal structure of bis(μ3-isophthalato-κ3O:O′:O′′)(μ2-1,4-\ bis((2-propyl-1H-benzo[d]imidazol-1-yl)methyl)benzene-κ2N:N′)dizinc(II), C22H19N2O4Zn
- Crystal structure of poly[bis(adipate-κ4O,O′:O′′, O′′′)(1,4-bis(2-methyl-1H-benzo[d]imidazol-1-yl)benzene-κ2N:N′)dizinc(II), C36H38N4O8Zn2
- Crystal structure of N-(2-(2-oxoindolin-4-yl)ethyl)-N-propylpropan-1-aminium tetraphenylborate, C40H45BN2O
- Crystal structure of 1-(2,3-dihydro-4-methyl-3-phenyl-2-thioxothiazol-5-yl)-1-ethanone, C12H11NOS2
- Crystal structure of 3-(adamantan-1-yl)-1-[(4-benzylpiperazin-1-yl)methyl]-4-[(E)-(2,6-difluorobenzylidene)amino]-1H-1,2,4-triazole-5(4H)-thione, C31H36F2N6S
- Crystal structure of 6-(4-chlorophenyl)-3-(thiophen-2-yl)-[1,2,4]triazolo[3,4-b][1,3,4]-thiadiazole, C13H7ClN4S2
- Crystal structure of bis(ethanaminium) poly[bis(hexaselenido-κ2Se1,Se6)palladate(II)], C4H16N2PdSe12
- Crystal structure of 2-(3-(benzofuran-2-yl)-5-phenyl-4,5-dihydro-1H-pyrazol-1-yl)-4-phenylthiazole, C26H19N3OS
- Crystal structure of poly-[bis(μ3-5-hydroxyisophtalato-κ3O:O′:O′′)(μ2-1,4-bis(2-ethylbenzimidazol-1-ylmethyl)benzene-κ2N:N′)dizinc(II)], C40H30N4O5Zn2
- Crystal structure of poly-[(μ-1,4-bis(2-ethylbenzimidazol-1-ylmethyl)benzene-κ2N:N′)-bis(μ4-2,2′-(1,3-phenylene)diacetate-κ4O:O′:O′′:O′′′)dizinc(II)], C44H38N4O8Zn2
- Crystal structure of 5,17-bis-cyano-25,26,27,28-tetrapropyloxy-calix[4]arene, C42H46N2O4
- Crystal structure of poly-[μ-1,4-bis(2-ethylbenzimidazol-1-ylmethyl)benzene-κ2N:N′)-bis(μ3-5-hydroxyisophthalate(2–)-κ3O,O′:O′′)dicadmium(II)] monohydrate, C64H54N8O11Cd2
- Crystal structure of poly-[μ-1,4-bis(2-ethylbenzimidazol-1-ylmethyl)benzene-κ2N:N′)-bis(μ4-4,4′-sulfonyldibenzoato-κ4O:O′:O′′:O′′′)dicadmium(II)] monohydrate, C52H42N4O14Cd2
- Crystal structure of poly-[bis(μ4-adipato-κ4O:O′:O′′:O′′′)(μ2-1,4-bis((2-ethyl-1H-benzo[d]imidazol-1-yl)methyl)benzene-κ2N:N′)dizinc(II)], C38H42N4O8Zn2
- Crystal structure of (2-(2-chlorophenyl)-5-methyl-1,3-dioxan-5-yl)methanol, C12H15ClO3
- Crystal structure of 2-(4-Bromophenyl)-5-ethyl-1,3-dioxane-5-carboxylic acid, C13H15BrO4
- Crystal structure of (2-(4-bromophenyl)-5-ethyl-1,3-dioxan-5-yl)methanol, C13H17BrO3
- Crystal structure of 3-((1,3,5,7-tetraoxo-6-(pyridin-3-ylmethyl)-3,3a,4,4a,5,6,7,7a,8,8a-decahydro-4,8-ethenopyrrolo[3,4-f]isoindol-2(1H)-yl)methyl)pyridin-1-ium-κN-trichloridocobalt(II) hemihydrate, C24H22Cl3CoN4O4.5
- Crystal structure of 4-chloro-4′,6′-dichloro-2,2′-[propane-1,3-diyldioxybis(nitrilomethylidyne)]-diphenol, C17H14Cl3N2O4
- Crystal structure of 2-amino-4-(3-trifluoromethylphenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile, C17H13F3N2O2
- Crystal structure of bis(benzoato-κO)bis(4,4′-((1H-1,2,4-triazol-1-yl)methylene)dibenzonitrile-κN)zinc(II), C48H32N10O4Zn
- Crystal structure of 3-methyl-2H-chromen-2-one, C10H8O2
- Crystal structure of catena-poly-[aqua-(2-carboxy-5-(3-carboxy-5-carboxylatophenoxy)benzoato-κO)(μ2-4,4′-di(1H-imidazol-1-yl)-1,1′-biphenyl-κ2N:N′)cobalt(II)], C34H24N4O10Co
- Crystal structure of 4,4′-di(1H-imidazol-1-yl)-1,1′-biphenyl, C36H28N8
- Crystal structure of 1-(3-chloropropyl)piperidin-1-ium tetraphenylborate, C32H37BClN
- Crystal structure of dimethyl 5-(benzylamino)isophthalate, C17H17NO4
- Crystal structure of dimethyl 5-(dibenzylamino)isophthalate, C24H23NO4
- Crystal structure of N-(adamantan-1-yl)-4-phenylpiperazine-1-carbothioamide, C21H29N3S
- Crystal structure of (2,2′(cyclohexane-1,2-diylbis(nitrilo(E)methylylidene))diphenolato-κ4O,O′,N,N′)dimethanolmanganese(III) bromide, C22H28BrMnN2O4
- Crystal structure of 3,5,7-tris(morpholinomethyl)tropolone·0.67 hydrate, C22H33N3O5·0.67H2O
- Crystal structure of biphenyl-2,3′,5,5′-tetracarboxylic acid – 4,4′-biphenyl-4,4′-diyldipyridine (3/2), C49H34N3O8
Comments (0)